comunicazioni orali sabato 24 e domenica 25 …individuals with non-alcoholic fatty liver disease...

GUIDOBACCELLI

ADOLFOFERRATA

CESAREFRUGONI

LUIGICONDORELLI

NICOLADIOGUARDI

COMUNICAZIONI ORALISABATO 24 E DOMENICA 25 OTTOBRE 2020

12.30 COMUNICAZIONI ORALIModeratori: Antonio Cittadini (Napoli), Chiara Pes (Sassari)

EFFECTS OF EMPAGLIFLOZIN ON MYOCARDIALMETABOLIC RATE OF GLUCOSE ESTIMATED THROUGHCARDIAC 18FDG PET IN PATIENTS WITH TYPE 2 DIABETES Succurro E.1, Pedace E.1, Papa A.2, Vizza P.1, Veltri P.1, PerticoneF.1, Cascini G.L.2, Sesti G.31Department of Medical and Surgical Sciences, University MagnaGraecia of Catanzaro; 2Department of Experimental and ClinicalMedicine, Magna Graecia University of Catanzaro; 3Departmentof Clinical and Molecular Medicine, University of Rome-Sapienza

ASSOCIATION BETWEEN ATHEROSCLEROTIC BURDEN ANDGUT-DERIVED LIPOPOLYSACCHARIDESOrlando F.1, Loffredo L.1, Ivanov V.2, Ciobanu N.2, DeseatnicovaE.3, Gutu E.4, Mudrea L.3, Ivanov M.2, Nocella C.5, CammisottoV.1, Pannunzio A.1, Palumbo I.1, Cosenza M.1, Paraninfi A.1,Ciacci P.1, Bartimoccia S.5, Carnevale R.6, Violi F.51Department of Clinical, Internistic, Anaesthetic andCardiovascular Sciences, Sapienza University, Rome, Italy.;2Moldavian Research Institute of Cardiology, Chisinau, Republicof Moldova; 3Department of Rheumatology and Nephrology,Nicolae Testemitanu State University of Medicine andPharmacy, Chisinau, Republic of Moldova, Chisinau, Republic ofMoldova; 43rd Department of General Surgery, NicolaeTestemitanu State University of Medicine and Pharmacy,Chisinau, Republic of Moldova, Chisinau, Republic of Moldova;5Department of Clinical, Internistic, Anaesthetic andCardiovascular Sciences, Sapienza University, Rome, Italy;6Department of Medical-Surgical Sciences and Biotechnologies,Sapienza University of Rome, Latina, Italy

TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) ISRELATED TO RESIDUAL THROMBOXANE DEPENDENTPLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETESMELLITUS RECEIVING LOW DOSE ASPIRIN Simeone P.G.1, Tripaldi R.1, Ciotti S.1, Liani R.1, Cavalca V.2,Camera M.2, Tremoli E.3, Cipollone F.1, Santilli F.11Department of Medicine and Aging, Center for AdvancedStudies and Technology (CAST), University “G. d’Annunzio” ofChieti-Pescara, 66100 Chieti, Italy; 2Monzino CardiologyCenter, IRCCS, Milan, Italy; 3Monzino Cardiology Center,IRCCS, Milan, Italy

MANP IN SUBJECTS WITH HYPERTENSION AND METABOLICSYNDROME: A NOVEL ATRIAL NATRIURETIC PEPTIDE-BASEDPOTENTIAL THERAPY FOR CARDIOMETABOLIC DISEASE McKie P.M.1, Iyer S.R.1, Scott C.2, Bailey K.2, Johnson B.K.2,Benike S.1, Horng H.C.1, Miller W.3, Volpi R.4, Cabassi A.4,Burnett JC Jr1, Cannone V.51Cardiorenal Research Laboratory, Division of CirculatoryFailure, Department of Cardiovascular Medicine, Mayo Clinic,Rochester, MN, USA; 2Division of Biomedical Statistics andInformatics, Mayo Clinic, Rochester, MN, USA; 3Department ofCardiovascular Medicine, Mayo Clinic, Rochester, MN, USA;4Clinica e Terapia Medica, Dipartimento di Medicina eChirurgia, Università di Parma, Parma, Italy; 5Clinica e TerapiaMedica, Dipartimento di Medicina e Chirurgia, Università diParma, Parma, Italy and Cardiorenal Research Laboratory,Division of Circulatory Failure, Department of CardiovascularMedicine, Mayo Clinic, Rochester, MN, USA

SABATO 24 OTTOBRE 2020 - SALA 1 SABATO 24 OTTOBRE 2020 - SALA 1

INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASEHAVE A COMPROMISED MYOCARDIAL MECHANO-ENERGETIC EFFICIENCY Fiorentino T.V.1, Pultrone S.1, Miceli S.1, Succurro E.1, SciacquaA.1, Andreozzi F.1, Sesti G.21Department of Medical and Surgical Sciences, UniversityMagna Graecia of Catanzaro; 2Department of Clinical andMolecular Medicine, University Sapienza of Rome

ACCUMULATING LONG-TERM METABOLIC SIDE EFFECTSFROM COVID-19 LOCKDOWN. LOOKING AT WEIGHT GAIN,LIFESTYLES, AND THREATS TO WORLD Shanmugam, H., Di Palo, D.M., Molina-Molina, E., Zingarelli,R.G., Pugliese, S., Di Ciaula, A., Portincasa, P. Clinica Medica “A. Murri”, Department of Biomedical Sciencesand Human Oncology, University of Bari ‘Aldo Moro’, Bari, Italy

12.30 COMUNICAZIONI ORALIModeratori: Riccardo Volpi (Parma), Matteo Traversa (Torino)

CORRELATION BETWEEN CARDIOVASCULAR RISK ANDDISEASE ACTIVITY SCORES IN A COHORT OF PATIENTSWITH SYSTEMIC LUPUS ERYTHEMATOSUS Cordeddu W., Depau C., Del Giacco S.R., Firinu D. Dipartimento di scienze Mediche e Sanità Pubblica, Universitàdegli Studi di Cagliari

SUPERIORITY OF INTERFERON-BASED OVER INTERFERON-FREE THERAPY ON IMMUNOLOGIC AND CLINICALOUTCOMES OF HCV-CURED CRYOGLOBULINEMIA Colantuono S., Marrapodi R., Del Padre M., Collalti G., Garzi G.,De Santis A., Fiorilli M., Basili S., Visentini M., Casato M. 1Department of Translational and Precision Medicine, SapienzaUniversity of Rome, Italy

SWITCH OR SWAP STRATEGY IN TAKAYASU ARTERITISPATIENTS FAILING TNFA (TNFI) INHIBITORS? Campochiaro C.1, Tomelleri A.1, Galli E.2, Cocchiara E.2,Sartorelli S.1, Muratore F.2, Catanoso M.G.2, Baldissera E.1,Ravelli A.3, Salvarani C.1, Dagna L.11Unit of Immunology, Rheumatology, Allergy and RareDiseases, IRCCS San Raffaele Hospital, Vita-Salute San RaffaeleUniversity; 2Rheumatology Unit, Department of SpecialisticMedicine, Azienda USL-IRCCS di Reggio Emilia, Italy; 3IstitutoGiannina Gaslini, Genova, Italy


THE PATTERN OF CD26 EXPRESSION ON CIRCULATING TLYMPHOCYTES IS ALTERED IN PATIENTS WITH IDIOPTAHICINFLAMMATORY MYOPATHIES De Lorenzo R.1, Sciorati C.2, Monno A.2, Canti V.3, Tronci S.1,Calvisi S.3, Conte C.4, Manfredi A.5, Previtali S.6, Rovere Querini P.51Vita-Salute San Raffaele University; 2San Raffaele ScientificInstitute; 3San Raffaele Hospital; 4San Raffaele Hospital, Vita-Salute San Raffaele University; 5San Raffaele Hospital, SanRaffaele Scientific Institute, Vita-Salute San Raffaele University;6San Raffaele Hospital, San Raffaele Scientific Institute

RAPID MOLECULAR TESTS FOR GRAM-NEGATIVEBACTEREMIA IN THE ERA OF MULTI-RESISTANTINFECTIONS: A MATTER OF TIME. Da Prat V.1, Galli L.2, Cichero P.3, Castiglioni B.2, Oltolini C.2,Tassan Din C.2, Andolina A.2, Poli A.2, Moro M.4, Ambrosio A.4,Clementi M.3, Lazzarin A.2, Tresoldi M.1, Castagna A.2,Scarpellini P.2, Ripa M.21General Medicine and Advanced Care Unit, San RaffaeleHospital, Milano, Italy; 2Department of Infectious Diseases, SanRaffaele Hospital, Milano, Italy; 3Laboratory of Microbiologyand Virology, San Raffaele Hospital, Milano, Italy; 4San RaffaeleHospital, Milano, Italy

DALBAVANCIN IN BACTERIAL SPONDYLODISCITIS: A CASE SERIES Lugarà M., Guida A., De Sena A., Sellitto A., Silvestri N., Tirelli P., Madonna P., Oliva G, Coppola MG., Bologna C., Turino C., De Luca C., Grasso E. UOC Medicina Generale PO Ospedale del Mare, ASL Napoli 1centro, Napoli

12.30 COMUNICAZIONI ORALIModeratori: Stefano Del Giacco (Cagliari), Rosanna Villani (Foggia)

PRE-COVID-19 PNEUMONIA WERE NOT CHARACTERIZEDBY “ATYPICAL” MANIFESTATIONS Di Stefano M., Garolfi M., Pagani E., Miceli E., Mengoli C.,Lapia F., Bonaso V., Di Sabatino A. Internal Medicine Unit, IRCCS S. Matteo Hospital, University ofPavia, Italy

A CLINICAL RISK SCORE TO PREDICT SEVERE OUTCOME INPATIENTS HOSPITALIZED FOR COVID-19: THE SIMI SCORE. Ageno W.1, Cogliati C.2, Girelli D.3, Pizzolo F.3, Olivieri O.3,Cattaneo M.4, Tombolini E.4, Benetti A.5, Corradini E.6,Pietrangelo A.61Dipartimento di Medicina e Chirurgia, Università degli Studidell’Insubria, Varese; 2Medicina Interna, Ospedale Sacco,Milano; 3Dipartimento di Medicina, Università degli Studi diVerona; 4Dipartimento di Scienze della Salute, Università degliStudi di Milano; 5Medicina Interna, Ospedale San Paolo,Milano; 6Dipartimento di Medicina, Università di Modena eReggio Emilia

LUNG ULTRASOUND IN COVID-19 PATIENTS ADMITTED TOTWO INTERNAL MEDICINE WARDS Barchiesi M.1, Leidi F.1, Russo G.1, Valerio G.1, Casella F.1, Del Medico M.1, Torzillo D.1, Magenta M.2, Zanetti M.2, Samartin F.2, Cogliati C.11Medicina ad Indirizzo Fisiopatologico, Ospedale Luigi Sacco,ASST-FBF-Sacco, Milano; 2Medicina Generale, Ospedale LuigiSacco, ASST-FBF-Sacco, Milano


PATTERN OF EMERGENCY DEPARTMENT REFERRALDURING THE COVID-19 OUTBREAK IN ITALY De Benedittis C.1, Bellan M.2, Gavelli F.1, Patrucco F.3, HaydenE.1, Soddu D.1, Pedrinelli A.R.1, Cittone M.G.1, Rizzi E.1, CasciaroG.F.1, Vassia V.1, Landi R.1, Menegatti M.4, Gastaldello M.L.1,Beltrame M.1, Labella E.1, Tonello S.5, Avanzi G.C.1, Pirisi M.1,Castello L.M.1, Sainaghi P.P.21Dipartimento di Medicina Traslazionale, Università delPiemonte Orientale, Novara - Divisioni di Medicina Interna e diMedicina d’Urgenza, “AOU Maggiore della Carità”, Novara;2Dipartimento di Medicina Traslazionale, Università delPiemonte Orientale, Novara - CAAD, Centre for Autoimmuneand allergic diseases, Novara - Divisioni di Medicina Interna edi Medicina d’Urgenza, “AOU Maggiore della Carità”, Novara;3Dipartimento di Medicina Traslazionale, Università delPiemonte Orientale, Novara; 4Divisioni di Medicina Interna e diMedicina d’Urgenza, “AOU Maggiore della Carità”, Novara;5Dipartimento di Medicina Traslazionale, Università delPiemonte Orientale, Novara - Divisioni di Medicina Interna

OCCURRENCE OF PNEUMOTHORAX IN COVID19 PATIENTSVENTILATED WITH CPAP Gidaro A.1, Samartin F.1, Cogliati C.1, Brambilla A.2, Ingrassia S.2,Cupiraggi V.2, Bonino C.2, Banfi F.2, Merlo A.1, Salvi E.11U.O.C. Medicina Generale H. Sacco ASST FBF-SaccoMilano;2U.O.C. Pronto Soccorso e Medicina D’Urgenza H.Sacco ASST FBF-Sacco Milano

PERFORMANCE OF DIFFERENT PROGNOSTIC SCORESYSTEMS IN PREDICTING IN-HOSPITAL MORTALITY IN ACOHORT OF COVID-19 PATIENTS WITH INTERSTITIALPNEUMONIA ADMITTED TO AN ACUTE MEDICAL UNIT Accordino S.1, Cazzaniga M.2, Formagnana P.1, Vezza C.1, CaccoS.1, Canetta C.11Ospedale Maggiore ASST Crema - UO Medicina Generale e diAccettazione e Urgenza; 2Presidio Ospedaliero A. ManzoniASST Lecco - UO Pronto Soccorso


12.30 COMUNICAZIONI ORALIModeratori: Carlo Agostini (Padova), Damiano D'Ardes (Chieti)

FIBROBLASTS-DERIVED EXOSOMES MEDIATE DRUGRESISTANCE IN MULTIPLE MYELOMA VIA SELECTIVE miRNATRANSFER Saltarella I.1, Desantis V.1, Lamanuzzi A.1, Di Marzo L.1, MelaccioA.1, Curci P.2, Annese T.3, Nico B.3, Ria R.4, Musto P.2, Vacca A.4,Frassanito M.A.41Department of Biomedical Sciences and Human Oncology(DIMO), Internal Medicine Section, University of Bari MedicalSchool, Bari, Italy.; 2Haematology and BMT Unit, University ofBari Medical School, Policlinico, Italy; 3Department of BasicMedical Sciences, Neurosciences and Sense Organs, Universityof Bari Medical School, Bari, Italy; 4Department of BiomedicalSciences and Human Oncology (DIMO), Internal MedicineSection, University of Bari Medical School, Bari, Italy

CLINICAL PRESENTATION OF NON-TRANSFUSIONDEPENDENT THALASSEMIA WITH TRIPLICATED a GENESCOINHERITED WITH b THALASSEMIA MUTATION Migone De Amicis M.1, Motta I.2, Marcon A.2, Cassinerio E.1,Branchi A.2, Maira D.3, Scaramellini N.3, Ferraresi M.3, Baldini M.1, Cappellini M.D.2, Graziadei G.41Fondazione IRCCS Ca’ Granda, Ospedale MaggiorePoliclinico, Dipartimento di Medicina Interna, UOC MedicinaGenerale, Milano; 2Università Degli Studi Di Milano,Dipartimento di Scienze Cliniche e di Comunità; 3Universitàdegli Studi di Milano, Scuola di Specializzazione in MedicinaInterna; 4Fondazione IRCCS Ca’ Granda, Ospedale MaggiorePoliclinico, Dipartimento di Medicina Interna, UOC MedicinaGenerale, Centro Malattie Rare Internistiche, Milano

ADHESION-MEDIATED MULTIPLE MYELOMA DISEASEPROGRESSION: CENTRAL FUNCTION FOR JUNCTIONALADHESION MOLECULE-A (JAM-A) AND ADAM17 INANGIOGENESIS, MULTIPLE MYELOMA DISSEMINATIONAND CLINICAL PROGNOSIS. Solimando A.G.1, Da Viá M. C.2, Leone P.1, Croci G. A.3, BorrelliP.4, Tabares P.5, Brandl A.5, Malerba E.1, Terragna C.6, Ribatti D.7,Cavo M.6, Racanelli V.1, Einsele H.5, Beilhack A.5, Vacca A.11Department of Biomedical Sciences and Human Oncology,Unit of Internal Medicine “Guido Baccelli”, University of BariAldo Moro Medical School, Policlinico, Bari, Italy; 2Departmentof Oncology and Hemato-Oncology, University of Milan, Milan,Italy; 3Pathology Unit, Department of Pathophysiology andTransplantation, University of Milan and Fondazione IRCCS, Ca’Granda - Maggiore Policlinico, Milan, Italy; 4Department ofMedical, Oral and Biotechnological Sciences, Laboratory ofBiostatistics, University “G. d’Annunzio” Chieti-Pescara, Italy;5Department of Medicine II, University Hospital of Würzburg,Würzburg, Germany; 6Institute of Hematology “L. and A.Seràgnoli”, Bologna; 7Department of Basic Medical Sciences,Neurosciences and Sensory Organs, University of Bari AldoMoro Medical School, Policlinico, Bari, Italy


EFFICACY OF CAPLACIZUMAB IN PATIENTS WITH aTTP INTHE HERCULES STUDY ACCORDING TO BASELINESEVERITY Coppo P.1, Cataland S.2, F. Peyvandi3, Knoebl P.4, Scully M.5,Kremer Hovinga J. A.6, Metjian A.7, de La Rubia J.8, PavenskiK.9, De Winter H.10, de Passos Sousa R.11, Callewaert F.121Department of Hematology, Reference Center for ThromboticMicroangiopathies (CNR-MAT), SaintAntoine UniversityHospital, AP-HP, Paris, France; 2Division of Hematology,Department of Internal Medicine, The Ohio State University,Columbus, OH, USA; 3Angelo Bianchi Bonomi Hemophilia andThrombosis Center, Fondazione IRCCS Ca’ Granda OspedaleMaggiore Policlinico, and Department of Pathophysiology andTransplantation, Università degli Studi di Milano, Milan, Italy;4Department of Medicine 1, Division of Hematology andHemostasis, Medical University of Vienna, Vienna, Austria;5Department of Haematology, University College LondonHospitals, Cardiometabolic Programme, National Institute forHealth Research UCLH-UCL Biomedical Research Center,London, United Kingdom; 6Department of Hematology andCentral Hematology Laboratory, Inselspital, Bern UniversityHospital, University of Bern, Bern, Switzerland; 7Department ofMedicine, Duke University School of Medicine, Durham, NC,USA; 8Hematology Department, Internal Medicine, School ofMedicine and Dentistry, Catholic University of Valencia andHospital Doctor Peset, Valencia, Spain; 9Departments ofMedicine and Laboratory Medicine, St. Michael’s Hospital andUniversity of Toronto, Toronto, ON, Canada; 10Formerly ClinicalDevelopment, Ablynx, a Sanofi company, Ghent, Oost-Vlaanderen, Belgium

SERUM URIC ACID LEVELS AND THE RISK OF RECURRENTVENOUS THROMBOEMBOLISM De Lucchi L.1, Nardin C.1, Sponchiado A.1, Raggi D.2, CallegariE.1, Cinetto F.1, Agostini C.1, Rattazzi M.11Dipartimento di Medicina, DIMED, Università degli Studi diPadova, Medicina Generale I^, Ospedale Cà Foncello, Treviso;2Dipartimento di Economia, Università di Bologna

PLASMA CONCENTRATION OF ACTIVATED FACTOR VII–ANTITHROMBIN, BUT NOT TISSUE FACTOR PATHWAYINHIBITOR AND FACTOR VII LEVELS, PREDICTS MORTALITYIN SUBJECTS WITH LIVER AND COLON CANCERUNDERGOING CURATIVE SURGICAL INTERVENTION. Moruzzi S.1, Castagna A.1, De Santis D.1, Udali S.1, Baroni M.2,Pattini P.1, Ruzzenente A.3, Conci S.3, Campagnaro T.3,Woodhams B.4, Van Dreden P.5, Guglielmi A.3, Bernardi F.2,Oliviero O.1, Friso S.1, Martinelli N.11Department of Medicine, University of Verona, Verona, Italy;2Department of Life Sciences and Biotechnology, University ofFerrara, Ferrara, Italy ; 3Department of Surgery, University ofVerona, Verona, Italy; 4Haemacon Ltd, Bromley, Kent, UnitedKingdom; 5Clinical Research Department, Diagnostica Stago,Gennevilliers, France


12.30 COMUNICAZIONI ORALIModeratori: Gaetano F. Mauro (Crotone), Elena Buzzetti (Modena)

RESPONSE TO TERLIPRESSIN AND ALBUMIN ISASSOCIATED WITH IMPROVED LIVER TRANSPLANTOUTCOMES IN PATIENTS WITH HEPATORENAL SYNDROME. Piano S.1, Gambino C.1, Vettore E.2, Calvino V.1, Tonon M.1,Boccagni P.3, Gringeri E.3, Germani G.4, Burra P.4, Cillo U.3, Angeli P.11Unit of Internal Medicine and Hepatology (UIMH), Department ofMedicine (DIMED), University of Padova, Italy; 2Internal MedicineUnit, Ospedale Dell’Angelo, ULSS 3 Serenissima, Mestre, Italy;3Hepatobiliary Surgery and Liver Transplantation, Department ofSurgery, Oncology and Gastroenterology, University of Padova,Italy; 4Multivisceral Transplant Unit, Department of Surgery,Oncology and Gastroenterology, University of Padova, Italy

SAFETY AND EFFICACY OF DIRECT ORALANTICOAGULANTS IN PATIENTS WITH ADVANCED LIVERDISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Menichelli D.1, Podda G.2, Pignatelli P.1, Di Rocco A.3, Ronca V.41I Clinica Medica, Atherothrombosis Centre, Department ofClinical, Internal, Anesthesiologic and Cardiovascular Sciences,Sapienza University of Rome; 2Medicina 2 ASST Santi Paolo eCarlo, Dipartimento di Scienze della Salute, Università degliStudi di Milano; 3Department of Public Health and InfectiousDiseases, Sapienza University of Rome; 4Division ofGastroenterology, Centre for Autoimmune Liver Disease,European Reference Network on Hepatological Diseases (ERNRARE-LIVER), Department of Medicine and Surgery, Universityof Milan-Bicocca

CLEARANCE OF HEPATITIS C VIRUS BY DIRECT-ACTINGANTIVIRALS TREATMENT REDUCES THE INCIDENCE OFTYPE 2 DIABETES MELLITUS. A PROSPECTIVEMULTICENTER STUDY. Pafundi P.C.1, Nevola R.1, Galiero R.1, Carlo Acierno1, Caturano A.1, Rinaldi L.1, Petta S.2, Francanzani A.L.3, Coppola C.4, Narciso V.5, Calvaruso V.2, Lombardi R.3, Staiano L.4, Di Marco V.2, Solano A.5, Marrone A.1, Saturnino M.4, Rini F.2, Guerrera B.1, Troina G.2, Giordano M.1,Craxi A.2, Sasso F.C.1, Adinolfi L.E.11University of Campania Luigi Vanvitelli, Department ofAdvanced Medical and Surgical Sciences, Naples - Italy.;2University of Palermo, Division of Gastroenterology andHepatology, PROMISE, Palermo, Italy; 3University of Milan,Fondazione Ca’ Granda IRCCS Ospedale Maggiore Policlinico,Department of Pathophysiology and Transplantation, Italy;4Gragnano Hospital, ASL Napoli 3 Sud, Unit of Internal Medicineand Hepatolology, Gragnano, Napoli, Italy; 5Pellegrini Hospital,ASL Napoli 1 Centro, Unit of Hepatology, Naples, Italy

PLATELET AGGREGABILITY AND ENDOTHELIALDYSFUNCTION IN THE DEVELOPMENT OF PORTAL VEINTHROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS:RESULTS FROM THE AGGREGOLIVER STUDY Cuoghi C.1, Marcacci M.1, Lelli N.2, Marchini S.1, Vegetti A.1,Vaccari D.1, Trenti T.2, Pietrangelo A.1, Ventura P.11Struttura Complessa di Medicina Interna, Dipartimento diScienze Mediche e Chirurgiche Materno-Infantili e dell’Adulto,Azienda Ospedaliero-Universitaria Policlinico di Modena,Università degli Studi di Modena e Reggio Emilia; 2StrutturaComplessa Medicina di Laboratorio, Ospedale CivileSant’Agostino Estense, Dipartimento Integrato Interaziendaledi Medicina di Laboratorio e Anatomia Patologica

DOMENICA 25 OTTOBRE 2020 - SALA 1 DOMENICA 25 OTTOBRE 2020 - SALA 1

NON-ALCOHOLIC FATTY LIVER DISEASE HAS NOT ANEGATIVE PROGNOSTIC VALUE ON SURVIVAL IN THEELDERLY POPULATION Tallarico V., Recinella G., Baietti E., Evangelisti E., Pirazzoli E.,Zoli M., Bianchi G. Università di Bologna, Policlinico S.Orsola-Malpighi

METABOLIC COMORBIDITIES AND OVERWEIGHT FAVOURNEW ONSET STEATOSIS AND PREVENT STEATOSISRESOLUTION AFTER VIRAL ERADICATION IN PATIENTSWITH CHRONIC HEPATITIS C TREATED BY DIRECT-ACTINGANTIVIRAL THERAPY: EVALUATION BY CONTROLLEDATTENUATION PARAMETER (CAP) Cespiati A.1, Lombardi R.1, Petta S.2, Sigon G.1, Pisano G.1, FattaE.1, Bertelli C.1, Fracanzani A.L.11Department of Pathophysiology and Transplantation Ca’Granda IRCCS Foundation, Policlinico Hospital, University ofMilan; 2Sezione di Gastroenterologia e Epatologia, Di.Bi.M.I.S.,University of Palermo, Italy

12.30 COMUNICAZIONI ORALIModeratori: Paola Andreozzi (Roma), Andrea Dalbeni (Verona)

EPICARDIAL ADIPOSE TISSUE INFLAMMATION BUT NOTOBESITY PREDICTS CLINICAL OUTCOMES IN COVID-19 Conte C.1, Esposito A.2, De Lorenzo R.3, Di Filippo L.3, PalmisanoA.3, Vignale D.3, Leone R.3, Nicoletti V.3, Ruggeri A.1, Secchi A.2,Bosi E.2, Tresoldi M.1, Castagna A.2, Landoni G.2, Zangrillo A.2,Decobelli F.2, Ciceri F.2, Camici P.2, Rovere Querini P.21IRCCS San Raffaele Hospital, Milan; 2Vita-Salute San RaffaeleUniversity and IRCCS San Raffaele Hospital, Milan; 3Vita-SaluteSan Raffaele University, Milan

RELATIONSHIP BETWEEN HYPOALBUMINEMIA ANDCOAGULOPATHY IN HOSPITALIZED COVID-19 PATIENTS. Wu M.A.1, Taino A.1, Trombetta L.1, Passeri M.2, Facchinetti P.1,Giaretta M.2, Lazzari B.2, Marchetti A.1, Messina V.2, Arquati M.3,Colombo R.2, Cogliati C.11Division of Internal Medicine, ASST Fatebenefratelli Sacco,Luigi Sacco Hospital, University of Milan, Milan, Italy; 2Divisionof Anesthesiology and Intensive Care, ASST FatebenefratelliSacco, Luigi Sacco Hospital, University of Milan, Milan, Italy;3Division of Emergency Medicine, ASST Fatebenefratelli Sacco,Luigi Sacco Hospital, University of Milan, Milan, Italy

HAEMOSTATIC CHANGES IN PATIENTS WITH COVID-19: A META-ANALYSIS WITH META-REGRESSIONS Calcaterra I.1, Lupoli R.2, Forte F.1, Vitelli N.1, Di Minno A.3,Ambrosino P.4, Di Minno M.N.D5

1Department of Clinical Medicine and Surgery, Federico II University,Naples, Italy; 2Department of Molecular Medicine and MedicalBiotechnologies, Federico II University, Naples, Italy; 3Department ofPharmacy, Federico II University, Naples, Italy; 4Istituti CliniciScientifici Maugeri IRCCS, Pavia, Italy; 5Department of TranslationalMedical Sciences, Federico II University, Naples, Italy


SYMPTOMS OF COVID-19 IN KIDNEY AND/OR BETA CELLTRANSPLANT RECIPENTS: A REPORT FROM THE INTERNALMEDICINE AND TRANSPLANTATION UNIT – IRCCS SANRAFFAELE HOSPITAL Catarinella D.1, Secchi A.1, Conte C.1, Caldara R.2, Gremizzi C.2,Tentori S.2, Paloschi V.2, Lepore M.2, Pomaranzi C.1, Maffi P.21Università Vita-Salute San Raffale - Milano; 2IRCCS SanRaffaele, Milano

PULMONARY FUNCTION IN COVID-19 SURVIVORS: DATAFROM ONE-MONTH FOLLOW-UP Ferrante M.1, Calcaterra B.2, Falbo E.3, Cinel E.3, De Lorenzo R.3,Patrizi A.3, Cilla M.3, Castellani J.3, Compagnone N.3, Conte C.2,Bosi E.4, Mariani F.2, Rovere Querini P.51Vita-Salute San Raffaele University, Milan, Italy; 2IRCCS SanRaffaele Hospital, Milan, Italy; 3Vita-Salute San RaffaeleUniversity, Milan, Italy; 4IRCCS San Raffaele Hospital, Milan,Italy; Vita-Salute San Raffaele University, Milan, Italy; 5IRCCSSan Raffaele Hospital, Milan, Italy; Vita-Salute San RaffaeleUniversity, Milan, Italy

HOMEDOC: HELPING PHYSICIANS DURING THE COVID19CRISIS THROUGH AN EHEALTH PLATFORM AND MACHINELEARNING. Montagna M.1, Battezzati N.2, Guidotti R.3, Cavallone A.4,Masino P.2, Calzolai L.21Vita-Salute San Raffaele University; 2HomeDoc.it; 3Departmentof Computer Science, Aalto University, Espoo, Finland eDepartment of Neuroscience, Imaging and Clinical Sciences,University “G. D’Annunzio”, Chieti, Italy; 4Altran Italia

12.30 COMUNICAZIONI ORALIModeratori: Antonino Saitta (Messina), Sara Bianco (Novara)

IMPROVING THE PREDICTION OF IN-HOSPITAL DEATH FOR AHF ADOPTING EHMRG SCORE ANDECHOCARDIOGRAPHY IN THE EMERGENCY DEPARTMENT Giovenali L.1, Falsetti L.2, Consuelo F.1, Zaccone V.2, Sampaolesi M.1, Morciano P.1, Moroncini G.3, Fioranelli A.4,Viticchi G.5, Martino M.6, Scalpelli C.4, Burattini M.4, Tarquinio N.41Emergency Medicine Residency Program, Marche PolytechnicUniversity, Ancona, Italy; 2Internal and Subintensive MedicineDepartment, Azienda Ospedaliero-Universitaria “OspedaliRiuniti” di Ancona, Italy; 3Clinica Medica, Azienda Ospedaliero-Universitaria “Ospedali Riuniti” di Ancona, Italy, Ancona, Italy;4Internal Medicine Department, INRCA-IRCCS Hospital, Osimo(Ancona); 5Clinica di Neurologia, Azienda Ospedaliero-Universitaria “Ospedali Riuniti” di Ancona, Italy; 6Clinica diEndocrinologia, Azienda Ospedaliero-Universitaria “OspedaliRiuniti” di Ancona, Italy

HUMAN SERUM ALBUMIN AND MAJOR ADVERSECARDIOVASCULAR EVENTS IN PATIENTS WITH ISCHEMICHEART DISEASE: INSIGHTS FROM THE ENDOCRINEVASCULAR DISEASE APPROACH STUDY Recchia F.1, Romiti G.F.1, Rozzi G.1, Corica B.1, Cangemi R.1,Stefanini L.1, Viceconte N.2, Tanzilli G.2, Proietti M.3, Basili S.1,Raparelli V.4, Eva Investigators51Department of Translational and Precision Medicine, SapienzaUniversity of Rome, Rome, Italy; 2Department of CardiovascularSciences, Sapienza University of Rome, Rome, Italy;3Department of Clinical Sciences and Community Health,University of Milan, Milan, Italy; 4Department of ExperimentalMedicine, Sapienza University of Rome, Rome, Italy; 5SapienzaUniversity of Rome, Rome, Italy


SERUM LEVELS OF BRAIN-DERIVED NEUROTROPHICFACTORS IN PATIENTS WITH CHRONIC HEART FAILURE:THE ROLE OF b3-ADRENERGIC RECEPTOR VARIANTS Gambino G.1, Bencivenga L.1, Liccardo D.1, Cuocolo A.2,Perrone Filardi P.2, Vitale F.D.3, Cannavo A.1, Ferrara N.1, Rengo G.11Dipartimento di Scienze Mediche Traslazionali, Università degliStudi di Napoli “Federico II’’; 2Dipartimento di ScienzeBiomediche Avanzate Università degli Studi di Napoli“Federico II’’; 3Istituti Clinici Scientifici ICS Maugeri S.p.A.IRCCS, Istituto Scientifico di Telese Terme

LONG-TERM EFFECTS OF SACUBITRIL-VALSARTANTREATMENT ON METABOLIC AND CARDIOVASCULARPARAMETERS IN ELDERLY PATIENTS WITH HEART FAILUREWITH REDUCED EJECTION FRACTION - REAL LIFE DATA Armentaro G., Toscani A.F., Magurno M., Suraci E., Volpentesta M., Cassano V., Battaglia R., Filicetti E., Pinto A.,Maio R., Miceli S., Perticone F., Sciacqua A. Department of Medical and Surgical Sciences, University MagnaGræcia of Catanzaro

STANDARDISED EXERCISE TRAINING IS FEASIBLE, SAFEAND EFFECTIVE IN PULMONARY ARTERIAL AND CHRONICTHROMBOEMBOLIC PULMONARY HYPERTENSION -RESULTS FROM A LARGE EUROPEAN MULTICENTRERANDOMISED CONTROLLED TRIAL Marra A.M.1, MacKenzie A.2, Peacock A.J.2, Eichstaedt C.1,Benjamin N.1, Nechwatal R.3, Ulrich S.4, Saxer S.4, Bussotti M.5,Sommaruga M.5, Ghio S.6, Gumbiene L.7, E. Paleviciute7, E.Jureviciene7, Stanziola A.A.8, Kovacs G.9, Olschewski H.9,Barberà J.A.10, Blanco I.10, Spruit M.A.11, Franssen F.M.E.12, VonkNoordegraaf A.13, Reis A.14, Santos M.15, Gonçalves ViamonteS.15, Demeyer H.16, Delcroix M.16, Johnson M.2, Bossone E.17,Cittadini A.18, Gruenig E.1

1Centre for Pulmonary Hypertension, Thoraxklinik HeidelberggGmbH at Heidelberg University Hospital, Translational LungResearch Center Heidelberg (TLRC), German Center for LungResearch (DZL), Heidelberg, Germany; 2Scottish PulmonaryVascular Unit, Golden Jubilee National Hospital, Glasgow,United Kingdom; 3Rehabilitation Center Koenigstuhl,Heidelberg, Germany; 4Clinic of Pulmonology, UniversityHospital and University of Zurich, Zurich, Switzerland; 5CardiacRehabilitation Department, IRCCS Maugeri Clinical ScientificInstitutes, Milan, Italy ; 6Divisione di Cardiologia, FondazioneIRCCS Policlinico S Matteo, Pavia, Italy; 7Institute of ClinicalMedicine, Faculty of Medicine, Vilnius University, Vilnius,Lithuania; 8Department of Clinical Medicine and Surgery,Federico II University, Naples, Italy; 9Department of InternalMedicine, Div. Pulmonology, Medical University of Graz, Graz,Austria; 10Department of Pulmonary Medicine, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona and BiomedicalResearch Networking Center on Respiratory Diseases(CIBERES), Spain; 11Research and Devlopment, Ciro, Horn,Netherlands; Department of Respiratory Medicine, Maastricht ;12Department of Research and Education, CIRO, Horn, TheNetherlands; 13Amsterdam UMC, VU University Medical Center,Department of Pulmonology, Amsterdam CardiovascularSciences, 1081 BT Amsterdam, The Netherlands; 14Departmentof Internal Medicine, Hospital Geral de Santo António, Porto,Portugal; 15Centro de Rehabilitação do Norte, Porto, Portugal;16Department of Pneumology, University Hospital Leuven,Leuven, Belgium; 17Department of Cardiology, AntonioCardarelli Hospital, Naples, Italy; 18Department of TranslationalMedical Sciences, “Federico II” University Hospital and Schoolof Medicine, Naples, Italy


THE PREDICTIVE ROLE OF EDUCATION ATTAINMENT LEVELIN INDIVIDUALS WITH ISCHEMIC HEART DISEASE: ANALYSISFROM THE ENDOCRINE VASCULAR DISEASE APPROACH STUDY Raparelli V.1, Tucci C.2, Proietti M.3, Santomenna F.2, Lenzi A.1,Viceconte N.4, Tanzilli G.4, Corica B.2, Romiti G.F.2, Basili S.2, EVA Investigators51Department of Experimental Medicine, Sapienza University ofRome, Italy; 2Department of Translational and Precision Medicine,Sapienza University of Rome, Italy; 3Department of ClinicalSciences and Community Health, University of Milan, Italy;4Department of Cardiovascular Sciences, Sapienza University ofRome, Italy; 5Sapienza University of Rome, Italy

12.30 COMUNICAZIONI ORALIModeratori: Elsa Berardi (Bari), Vincenzo Zaccone (Ancona)

COULD PET/CT BE THE FIRST CHOICE FOR DIFFERENTIALDIAGNOSIS OF FEVER OF FUO/IUO? Tagliente T.1, Malandrino D.1, Allocca M.2, Olianti C.2, Poggesi L.1, Berni A.31Department of Experimental and Clinical Medicine, Universityof Firenze; 2Nuclear Medicine Unit, Department of Experimentaland Clinical Biomedical Sciences “Mario Serio”, University ofFlorence; 3Internal Medicine Unit 3, Careggi UniversityHospital, Firenze, Italy

THREE-MONTH MORTALITY IN PERMANENTLY BEDRIDDENMEDICAL NON-ONCOLOGIC PATIENTS. THE BECLAPSTUDY (PERMANENTLY BEDRIDDEN, CREATININECLEARANCE, ALBUMIN, PREVIOUS HOSPITAL ADMISSIONS STUDY) Cumetti D.F.1, Tiraboschi M.M.1, Cogliati C.2, Squizzato A.3,Pasina L.4, Tognoni G.5, Barbui T.6, Brucato A.L.71Medicina interna, ASST Papa Giovanni XXIII Bergamo;2Dipartimento di Medicina, Ospedale L. Sacco Milano;3Dipartimento di Medicina e Chirurgica, Università InsubriaVarese; 4IRCCS Mario Negri Milano; 5Dipartimento Anestesia-rianimazione e emergenza urgenza, Ospedale MaggiorePoliclinico Milano; 6Fondazione FROM Ricerca, ASST PapaGiovanni XXIII Bergamo; 7Dipartimento di scienze biomedichee cliniche, Università degli studi di Milano, OspedaleFatebenefratelli


PREDICTIVE FACTORS FOR RENAL DISEASE PROGRESSIONIN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARYDISEASE (COPD) Critelli R.1, Pastori D.2, Pelaia C.1, Barbara K.1, Scalise L.1,Cassano V.1, Caroleo B.1, Perticone M.1, Pignatelli P.2, Violi F.2,Sesti G.3, Perticone F.1, Sciacqua A.11Department of Medical and Surgical Sciences, UniversityMagna Græcia of Catanzaro; 2Department of Clinical Internal,Anesthesiologic, and Cardiovascular Sciences, SapienzaUniversity of Rome; 3Department of Clinical and MolecularMedicine, University of Rome-Sapienza

RENAL FUNCTION, INAPPROPRIATE DRUG PRESCRIPTIONAND CLINICAL OUTCOMES IN HOSPITALIZED ELDERLY:DATA FROM THE REPOSI REGISTRY Gigante A.1, Proietti M.2, Petrillo E.1, Mannucci P.M.3, Nobili A.4,Muscaritoli M.11Department of Translational and Precision Medicine, SapienzaUniversity of Rome, Italy; 2Department of Clinical Sciences andCommunity Health, University of Milan, Italy; 3ScientificDirection, Fondazione IRCCS Ca’ Granda Ospedale MaggiorePoliclinico, Milan, Italy; 4Department of Neuroscience, Istitutodi Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy

PROMINENT INVOLVEMENT OF BASAL LEFT VENTRICULARLONGITUDINAL STRAIN IN PATIENTS WITH MONOCLONALGAMMOPATHY OF UNDETERMINED SIGNIFICANCE Canonico M.E.1, Fiorillo L.2, Santoro C.1, Esposito L.1, Capone V.1, Casciano O.1, Cuomo V.2, Fedele T.2, Orefice S.2,Esposito R.21Dipartimento di Scienze Biomediche Avanzate, AOU FedericoII, Napoli; 2Dipartimento di Medicina Clinica e Chirurgia, AOUFederico II, Napoli

VERTEBRAL FRACTURE ASSESSMENT INPOSTMENOPAUSAL WOMEN WITH POST-SURGICALHYPOPARATHYROIDISM Cipriani C.1, Diacinti D.2, Pepe J.1, Diacinti D.3, Colangelo L.1,Piazzolla V.1, Angelozzi M.2, Nieddu L.4, Minisola S.11Department of Clinical, Internal, Anesthesiology andCardiovascular Sciences, Sapienza University of Rome, Italy;2Department of Radiological Sciences, Oncology andPathology, Sapienza University of Rome, Italy; 3Department ofOral and Maxillo-Facial Sciences, Sapienza University of Rome,Italy; Department of Diagnostic and Molecular Imaging,Radiology and Radiotherapy, University Tor Vergata, Rome,Italy; 4Faculty of Economics, UNINT University, Rome, Italy


comunicazioni orali sabato 24 e domenica 25 …individuals with non-alcoholic fatty liver disease...

Documents